Lymphopenia As an Early Predictor of Immune Related Adverse Events
ConclusionLymphopenia may be an early indicator of irAEs and should be investigated further in prospective trials.DisclosuresNo relevant conflicts of interest to declare.
Source: Blood - Category: Hematology Authors: Kamran, A., Otaibi, Z., Shah, R. A., Finley, G. Tags: 203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Health Management | Hematology | Immunotherapy | Kidney Cancer | Lung Cancer | Melanoma | Renal Cell Carcinoma | Skin Cancer | Study | Toxicology | Yervoy